![]() |
市场调查报告书
商品编码
1722881
骨整合植入物市场报告:2025 年至 2033 年按产品、材料、最终用户和地区分類的规模、份额、趋势和预测Osseointegration Implants Market Report Size, Share, Trends and Forecast by Product, Material, End User, and Region, 2025-2033 |
2024 年全球骨整合植入物市场规模价值为 71.1418 亿美元。展望未来, IMARC Group估计到 2033 年该市场规模将达到 113.4232 亿美元,2025 年至 2033 年的复合年增长率为 5.05%。北美目前占据市场主导地位,2024 年的市占率将超过 55.8%。市场主要受到人口老化加剧、牙科和骨科手术需求增加、植入技术进步、口腔健康意识增强、医疗保健基础设施扩大以及优惠报销政策实施的推动。
骨科和牙科疾病的盛行率不断上升,需要先进的植入解决方案才能有效治疗,这推动了全球骨整合植入物市场的发展。除此之外,致命道路交通事故的增加以及患有骨关节炎和类风湿性关节炎的人数的增加增加了对关节和膝关节置换手术的需求。这导致消费者对微创手术(MIS)的偏好日益增加,进而推动了市场的成长。除此之外,与改善耐用性、生物相容性和功能性的治疗相关的成长和创新正在推动市场的发展。例如,2024 年 3 月 28 日,Osstem Implant 推出了其 TSIII SOI 植入物,该植入物采用下一代超级骨整合 (SOI) 表面处理,可改善癒合并加强初始骨形成。这种新的表面处理方法使用紫外线和 HEPES 缓衝剂来创建超亲水涂层,可增强生物相容性并将骨整合期从长达六个月缩短至约两个月。此外,医疗保健支出的增加、政府的支持政策以及微创手术技术的采用的增长也促进了骨整合植入物在已开发市场和新兴市场的大规模渗透。
美国市场主要受到运动相关损伤和创伤病例日益增多的影响,这些病例需要先进的植入解决方案来进行復健和恢復。糖尿病和血管疾病等慢性病的发生率不断上升,常常导致截肢,从而推动了对骨整合义肢系统的需求。此外,完善的医疗保健基础设施和强有力的报销政策促进了医疗保健提供者和患者采用这些先进的植入物。此外,对整容和重建手术的需求不断增长,特别是寻求功能和美学增强的个人,也促进了市场的成长。除此之外,美国医疗器材製造商所进行的广泛研发活动以及该国骨整合植入技术的创新。例如,2024 年 9 月 9 日,SINTX Technologies 收到了美国专利商标局 (USPTO) 专利的授权通知,该专利涵盖将生物活性氮化硅黏合到氧化锆增韧氧化铝 (ZTA) 表面的方法。该公司继续扩大其智慧财产权组合,目前拥有 16 项美国专利。
骨骼相关疾病的盛行率不断上升
骨关节炎、骨质疏鬆症和先天性异常等骨骼疾病的发生率不断增加,是使用骨整合植入物的因素。全球老龄人口不断增长,增加了使用骨整合过程进行外科手术的需求,特别是在牙科和矫形义肢方面。对于人口结构中老年人口较多的已开发市场而言,其需求日益强烈。世界卫生组织估计,2019 年全球约有 5.28 亿人患有骨关节炎,比 1990 年增加了 113%。此外,73% 的骨关节炎患者年龄在 55 岁及以上。此外,其中60%为女性。因此,老年族群中骨关节炎盛行率的上升推高了对骨整合植入物的需求,因为大多数患者都需要进行关节置换等手术。因此,由于人口老化和骨骼疾病的增多,骨整合植入物市场正在大幅成长。
技术进步
植入物表面的材料、涂层和技术的创新正在彻底改变骨整合植入物的功效和效率。钛及其合金等生物相容性材料的开发进一步推动了市场的成长,这些材料确保了此类植入物具有更高的成功率,并为患者带来了耐用性和舒适性。此外,新的 3D 列印技术提供了创建客製化植入物的可能性,从而改善治疗效果和患者满意度。这些创新增加了医疗服务提供者对骨整合植入物的接受度,并简化了骨整合植入物的可近性和成本。 Keystone Dental Holdings 于 2023 年 11 月推出了 GENESIS ACTIVE 种植系统。这种创新的例子就是新型 GENESIS ACTIVE 植牙系统的进步,Keystone Dental Holdings 于 2023 年 11 月宣布推出该系统。这种牙科植牙手术解决方案推动了该行业的植入和修復技术的发展。持续的技术进步正在改善患者的治疗效果,同时使整个植入过程更加高效,并推动骨整合植入物市场的成长。
美容和功能性植入物需求不断增长
将功能优势与美观相结合的植入物的需求不断增长,尤其是在牙科应用中,这成为骨整合市场的重要成长动力。骨整合植体可以永久、自然地取代缺失的牙齿,兼具功能和美观的优势。这使得它们在希望改善生活品质的患者中非常受欢迎,主要原因是各地区医疗保健服务可近性和意识的提高。 2024年,世界卫生组织口腔健康报告持续反映口腔健康问题在全球持续存在。据估计,全球约有 20 亿人患有恆牙龋齿,约有 5.14 亿儿童患有乳牙龋齿,他们对骨整合植入物等更好的牙科解决方案的需求持续巨大。对先进牙科护理日益增长的需求是全球骨整合植入物市场扩张的重要驱动力。
The global osseointegration implants market size was valued at USD 7,114.18 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 11,342.32 Million by 2033, exhibiting a CAGR of 5.05% from 2025-2033. North America currently dominates the market, holding a market share of over 55.8% in 2024. The market is primarily driven by the increasing aging populations, rising demand for dental and orthopedic procedures, advancements in implant technologies, growing awareness about oral health, expanding healthcare infrastructure, and the implementation of favorable reimbursement policies.
The increasing prevalence of orthopedic and dental disorders, which require advanced implant solutions for effective treatment, is driving the global osseointegration implants market. In addition to this, the increasing number of fatal road traffic accidents and the growing number of individuals suffering from osteoarthritis and rheumatoid arthritis increases the need for joint and knee replacement surgeries. This leads to increasing consumer preferences for minimally invasive surgeries (MIS), which is propelling the growth of the market. Besides this, growth and innovations related to treatments improving durability, biocompatibility, and functionality, are fueling the market development. For instance, on March 28, 2024, Osstem Implant launched its TSIII SOI implant which boasts of the next-generation Super Osseointegration (SOI) surface treatment that improves healing and strengthens initial bone formation. This new surface treatment uses UV and HEPES buffering agents to create a super-hydrophilic coating that enhances biocompatibility and reduces the osseointegration period from up to six months to about two months. Apart from this, it is supported by the increasing healthcare expenditure, supportive government policies, and the growth in the adoption of minimally invasive surgical techniques for promoting the mass penetration of osseointegration implants in the developed and emerging markets.
The market in the United States is majorly influenced by the growing prevalence of sports-related injuries and trauma cases, which demand advanced implant solutions for rehabilitation and recovery. The rising incidence of chronic conditions like diabetes and vascular diseases, often leading to limb amputations, drives the demand for osseointegrated prosthetic systems. Moreover, a well-established healthcare infrastructure and strong reimbursement policies promote the adoption of these advanced implants among healthcare providers and patients. Additionally, the rising demand for cosmetic and reconstructive surgeries, particularly among individuals seeking functional and aesthetic enhancements, contributes to market growth. Besides this, the extensive research and development (R&D) activities undertaken by U.S.-based medical device manufacturers and the innovation of osseointegration implant technologies in the country. For example, on September 9, 2024, SINTX Technologies received a notice of allowance for a USPTO patent covering methods to bond bioactive silicon nitride to zirconia-toughened alumina (ZTA) surfaces. The company continues to grow its intellectual property portfolio, now holding 16 U.S. patents.
Growing Prevalence of Bone-related Disorders
Increasing incidences of bone conditions such as osteoarthritis, osteoporosis, and congenital anomalies are contributing factors to the use of osseointegration implants. An ever-growing elderly global population increases the desire for surgical operations using osseointegration processes, especially on dental and orthopedic prosthetics. There is an intensified demand for developed markets that account for older populations in their demographic groups. The World Health Organization estimates that around 528 million people across the globe were living with osteoarthritis in 2019, a 113% increase from 1990. In addition, 73% of individuals with osteoarthritis are aged 55 years and above. Moreover, 60% of these individuals are women. As a result, this increased prevalence of osteoarthritis among the elderly population is driving up the need for osseointegration implants since most of these patients require procedures like joint replacements. Thus, the osseointegration implants market is growing considerably due to an ageing population and a growing number of bone disorders.
Technological Advancements
Innovations in the materials, coatings, and techniques of implant surface are revolutionizing the efficacy and efficiency of osseointegration implants. Growth in the market is further fueled by the development of biocompatible materials, including titanium and its alloys, that ensure higher success rates for such implants, with patients experiencing durability and comfort. Also, the new 3D printing technologies are offering the possibility to create customized implants, thus bettering outcomes and patient satisfaction. These innovations increase osseointegration implant uptake by healthcare service providers and ease accessibility as well as their cost. Keystone Dental Holdings rolled out the GENESIS ACTIVE Implant System during November 2023. An example of such innovation is seen with the advancement of the new GENESIS ACTIVE Implant System, with Keystone Dental Holdings announcing it in November 2023. This dental implant surgical solution advances placement and restoration for the sector. Continued technological advancements are improving patient outcomes while making the overall process of implant procedures more efficient, and it is driving growth in the osseointegration implants market.
Rising Demand for Aesthetic and Functional Implants
The growing demand for implants that integrate functional advantages with aesthetic enhancement, especially in dental application, acts as a significant growth driver for the osseointegration market. Osseo integration implants provide a permanent and natural replacement of missing teeth that provides both functional and aesthetic advantages. This makes them highly in need among patients looking forward to improving the quality of their life, mainly driven by improving access and awareness in healthcare across the regions. In 2024, the World Health Organization report on oral health continues to reflect that oral health issues persist in the global scene. Estimated to have reached several about 2 billion, people suffering from caries in permanent teeth, and approximately 514 million children with caries in primary teeth, continue to present such immense demands for better dental solutions such as osseointegration implants. This growing demand for advanced dental care is a significant driving force behind the expansion of the osseointegration implants market across the world.
Bone-anchored prostheses lead the market in 2024. Bone-anchored prostheses are considered a revolutionary solution for those individuals requiring limb replacement or rehabilitation. The advanced nature of these prosthetic products makes use of osseointegration technology, which involves the direct integration of an implant with bone tissue, thereby offering stability, functionality, and comfort more than socket-based prosthetics. Their growing adoption is due to the increasing prevalence of amputations due to trauma, diabetes, and vascular diseases, coupled with rising awareness about advanced prosthetic options. Users in developed as well as developing markets witness high demand as bone-anchored prostheses can enhance their movement, diminish their pain and even improve the quality of their lives. Besides, the continuous development of implant materials and surgical procedures further enhances their market potential, which makes bone-anchored prostheses a significant product in the osseointegration implant market.
Metallic leads the market with around 63.5% of market share in 2024. Metallic materials are the mainstay of growth in the global osseointegration implants market, as they have excellent biocompatibility, durability, and mechanical strength. The most widely used metals, such as titanium and its alloys, are preferred for their osseointegration capability, especially for establishing a stable bonding with the bone tissue. These materials are resistant to corrosion and wear, which ensures the long-term functionality and reliability of implants used in dental, orthopedic, and maxillofacial applications. The growing need for durable, high-performance implants, especially for the aging population and for patients with trauma or degenerative conditions, gives vital significance to metallic materials in this market. Moreover, novel techniques in metal fabrication, for example, 3D printing and surface coating technologies, positively impact implant customization while further enhancing patient benefits.
Hospitals lead the market with around 65.9% of market share in 2024 due to the extensive provision of different types of medical services and surgical procedures that are provided for patients seeking proper care. Hospitals have an enormous client base with various types of patients in need of osseointegration implants. Patients may suffer from orthopedic, dental, or maxillofacial disorders and could be survivors of trauma and cancer requiring reconstruction solutions. A growth in surgeries combined with hospital admission due to the prevalence of conditions requiring implantation augments the demand for osseointegration implants. In addition to this, government and private investments in hospital facilities, especially in emerging economies, increase access to quality care, which in turn propels the growth of the market. Hospitals' ability to provide complete post-operative care and rehabilitation ensures optimal patient outcomes, which further strengthens their role in the expansion of the osseointegration implant market.
In 2024, North America accounted for the largest market share of over 55.8% due to advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a well-established regulatory framework. The increasing elderly population in the region and rising cases of trauma, osteoporosis, and dental conditions significantly fuel the demand for osseointegration implants. Countries like the United States and Canada have huge healthcare spending, strong reimbursement policies, and a strong presence of leading industry players, which fosters rapid adoption of advanced implants. Additionally, research and development (R&D) activities are further supported by funding from the government as well as the private sector to enhance product innovation and patient outcomes. With an increase in awareness regarding the advantages of osseointegration and a large percentage of the population suffering from chronic conditions requiring implants, North America is an essential contributor to the growth of the market. Its proactive attitude toward the adoption of cutting-edge medical solutions ensures sustained importance in the global market.
United States Osseointegration Implants Market Analysis
The United States is a significant region in the osseointegration implants market with the market share of 89.30%, due to the rise in the number of people with arthritis and mobility problems. According to the CDC, a report in 2024 stated that about 58.5 million adults aged 18 years and older are living with arthritis in the United States, with 25.7 million experiencing activity limitations due to arthritis. The projections indicate that, by 2040, this number will surge to 78 million adults, and this population is surely aged, attributed also to lifestyle, in musculoskeletal conditions. Arthritis is a primary cause of disability and surely does require surgical intervention like joint replacements, where osseointegration implants improve mobility and quality of life. Growing demand for advanced implants made from biocompatible materials, along with the increasing awareness of healthcare, is driving the growth of the market. In addition, efforts to increase access to orthopedic care are expected to boost the demand for osseointegration solutions in the United States.
Europe Osseointegration Implants Market Analysis
The Europe osseointegration market is expected to rise significantly due to the aging population in the region and the rise in osteoporosis. On January 1, 2023, the European Union population was 448.8 million, with one-fifth, or 21.3%, aged 65 years or above, according to the European Commission. This indicates the growing needs for medical interventions, such as osseointegration implants, to treat the bone-related condition associated with advancing age. Additionally, osteoporosis remains a serious health issue in Europe, where over 23 million people are at high risk of osteoporotic fractures, as NIH data in 2021 indicates. The majority of such fractures require surgery and implantation, which means the demand for more advanced osseointegration technologies is increased. Moreover, solid healthcare infrastructure combined with innovations happening in implantable materials and surgical techniques increase the success ratio of treatments for osseointegration, giving Europe a large market for its solutions.
Asia Pacific Osseointegration Implants Market Analysis
The Asia Pacific osseointegration implants market has high growth potential, as the region has a rapidly aging population and is witnessing rising osteomyelitis, among other bone-related disorders. According to NIH, the population aged 65 or older in China will grow more than double from 172 million or 12.0% of total population in 2020 to 366 million or 26.0% by 2050. This demographic change gives rise to increasing demand for state-of-the-art healthcare services. This encompasses conditions such as osteoporosis, arthritis, and joint degeneration, in addition to osseointegration implants. Also, the healthcare infrastructure is becoming more advanced within the region. There are enhanced investments in the medical technology space, thus paving the way for growth. It includes Japan-one of the most geriatric countries and India- one of the increasing healthcare conscious ones. Advances in implant materials, including personalized 3D printing of implants, improve success rates. Therefore, osseointegration implants are witnessing significant growth as the leading market area in the Asia Pacific region.
Latin America Osseointegration Implants Market Analysis
The Latin American osseointegration implants market is growing due to the increasing orthopedic disorder prevalence, primarily in Brazil. In this region, the growing demand for hip replacement surgeries supports the market expansion. According to estimates from the Brazilian Hip Society, there are about 70,000 hip arthroplasties performed annually. Only 17,000 of them are publicly funded, according to an NCBI report in 2020. Thus, this situation presents a sizeable opportunity for private healthcare service providers to help bridge the ever-growing demand gap for hip replacement and osseointegration implants. The aging population in Latin America and the rising awareness of advanced medical technologies are also contributing to the need for high-quality orthopedic implants. As more patients seek personalized and long-lasting solutions for conditions like osteoarthritis and osteoporosis, the market for osseointegration implants in Latin America is expected to continue its growth. The region is heading for tremendous gains in implant technology and patient care, thus offering some great opportunities that are expected in the coming years.
Middle East and Africa Osseointegration Implants Market Analysis
The Middle East and Africa (MEA) osseointegration implants market is witnessing significant growth with the increasing incidence of bone-related disorders like osteoarthritis (OA) and rising investments in healthcare. According to the NIH, the standardized prevalence of OA in the MENA region was 5,342.8 cases per 100,000 in 2019. This number rose by 9.3% from 1990. The growing case of OA, which is greatly promoted through the aging population, fuels the need for joint replacement surgeries, a scenario where osseointegration implants are fundamental. Additional strength to the increased demand for superior medical technologies that include osseointegration implants is provided with the increasing regional healthcare spending-estimated to stand at USD 135.5 Billion by the year 2027 in GCC, as per reports. Moreover, the rising preference and adoption of innovative and highly biocompatible materials in solutions from implant technology, which is currently enhancing the whole market growth through the MEA region.
The osseointegration implants market at the global level is highly competitive, with key manufacturers focusing on innovation, technology, and differentiation in products. The key companies majorly emphasize the research and development (R&D) activities of implant design, biocompatibility, and long-term durability. Companies have been investing significantly in minimally invasive solutions and personalized implants in order to bring better patient results. Market players are trying to increase their geographies through partnerships, collaboration, and distribution agreements. Rising consumption of advanced materials such as titanium and ceramic help in further innovation. Manufacturers target emerging markets by providing cost-effective solutions, which impact the market dynamics.